Financials
Value Q1, 25Q2, 25Q3, 25Q4, 25Q1, 26 TTM Selling/general/admin expenses 1.6 M1.44 M1.48 M1.25 M1.76 M 5.92 M Research & development 494.98 K629.38 K571.87 K458.44 K476.07 K 2.14 M Operating income -2 M-1.73 M-1.93 M-1.54 M-1.9 M -7.09 M Non-Operating Income, Total -25.1 K-64.71 K-50.64 K-31.36 K-51.99 K -198.7 K Interest expense, net of interest capitalized 11.76 K12.03 K12.31 K12.59 K7 381 44.32 K Non-Operating Income, excl. Interest Expenses -25.1 K-64.71 K-50.64 K-31.36 K-51.99 K -198.7 K Unusual income/expense ————— — Pretax income -2.04 M-1.81 M-1.99 M-7.36 M-1.96 M -13.12 M Equity in earnings ————— — Taxes ———-1.31 M0 — Non-controlling/minority interest ————— — After tax other income/expense ————— — Net income before discontinued operations -2.03 M-1.79 M-1.98 M-1.57 M-1.95 M -7.29 M Discontinued operations ————— — Net income -2.03 M-1.79 M-1.98 M-1.57 M-1.95 M -7.29 M Dilution adjustment ————— — Preferred dividends ————— — Diluted net income available to common stockholders -2.03 M-1.79 M-1.98 M-1.57 M-1.95 M -7.29 M Basic earnings per share (Basic EPS) -0.07-0.06-0.06-0.04-0.05 -0.21 Diluted earnings per share (Diluted EPS) -0.07-0.06-0.06-0.04-0.05 -0.21 Average basic shares outstanding 29.89 M30.1 M34.51 M32.62 M36.4 M — Diluted shares outstanding -64.61 M30.1 M34.51 M32.62 M36.4 M — EBITDA -1.99 M-1.72 M-1.91 M-1.52 M-1.9 M -7.05 M EBIT -2 M-1.73 M-1.93 M-1.54 M-1.9 M -7.09 M Cost of revenue —613.59 K1.02 M384.61 K791.84 K 2.81 M Other cost of goods sold ————— — Depreciation & amortization (cash flow) 11.76 K12.03 K12.31 K12.59 K7 381 44.32 K